Building a sample bank for faster diagnosis
Part of Infections clinical trials.
This study creates a bank of leftover blood and other samples from patients at two French hospitals. It helps researchers test new, faster ways to diagnose diseases.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older and are a patient at Bicêtre or Paul Brousse hospitals.
- You have leftover blood or other biological samples from your regular hospital care.
- You are covered by French social security (not State Medical Aid).
- You or a family member/legal representative can sign a consent form.
- You are not under guardianship or curatorship, and you are not in prison or detained.
- You can understand French, or you have a translator to help.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the immune system in the body responds to different COVID-19 virus variants. It may help improve how COVID-19 is diagnosed by comparing people who are currently infected and those who are not.
This study looks for genetic reasons why some people get very serious infections. If you or a family member has had a rare, severe infection, researchers will analyze your DNA to find genes that might make you more vulnerable.
This study collects blood and other samples from people with certain infectious diseases to build a biobank for future research. By participating, you help scientists better understand and develop treatments for these infections.
This study sets up a library (biobank) of biological samples and related health data from people with infectious or tropical diseases. Your samples and information help researchers study these illnesses and develop better tests or treatments.
This study collects blood and other samples from people who have, might have, or are at risk for new or re-emerging infectious diseases. It also looks at new treatments or vaccines that might be used against these diseases.
This study collects medical information and optional biological samples (like blood or saliva) from people with an active or suspected infection. The goal is to build a large database that can help researchers better understand infectious diseases and develop new ways to diagnose and treat them.
Hear when a new Communicable Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.